HHS Grants Enforcement Discretion for Six Peptides in 503A Compounding Pharmacies
The U. S. Department of Health and Human Services has announced a policy change that will allow small compounding pharmacies to manufacture six specific peptides without facing…
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 30 02:34 ETSource: PravdaReport
From the source
Read at english.pravda.ruHHS Grants Enforcement Discretion for Six Peptides in 503A Compounding Pharmacies
The U. S. Department of Health and Human Services has announced a policy change that will allow small compounding pharmacies to manufacture six specific peptides without facing federal enforcement action. While these substances have long been promoted for wellness and various medical conditions, they have not undergone the Food and Drug Administration's standard approval process and were previousl
